Stroke Updates Including Antiplatelet Management

Stroke Updates Including Antiplatelet Management - On Demand 2025

When minutes matter, precise antiplatelet decisions shape outcomes. In this on‑demand update, assess current acute ischemic stroke guidance, evaluate options for secondary prevention, and interpret emerging clinical trials to inform care. Implement single vs dual strategies thoughtfully, and manage bleeding and other complications with confidence—sharpening judgment for safer, individualized stroke treatment in 2025.

Create Account

Availability

On-Demand

Expires on May 06, 2028

Credit Offered

0.75 CME Credit

0.75 ABIM-MOC Point

0.75 Participation Credit

Overview
Faculty
Accreditation

Learning Objectives
After completing this activity, learners should be able to:

Assess the latest evidence-based guidelines for acute ischemic stroke management, including the role of early antipaltelet therapy.
Evaluate the benefits and risks of various antiplatelet agents in the context of secondary stroke prevention, tailoring choices to individual patient profiles.
Implement strategies for dual versus single antiplatelet therapy based on patient risk factors, stroke classification, and emerging clinical evidence.
Interpret clinical trial data regarding new antiplatlet agents and combination therapies, incorporating findings into patient care plans.
Recognize and manage antiplatlet therapy complications in stroke patients, optimizing outcomes through monitoring and personalized care adjustments.

Faculty

Joseph Caleb McCall, MD
Carrie Herzke, MD, SFHM, FAAP, FACP
Gopi Astik, MD, MS
Ebrahim Barkoudah, MD, FACP, MPH, SFHM
Jennifer Barnett, MPAS, PA-C, DFAAPA
Joanna Bonsall, MD, PhD, SFHM
Alfred Burger, MD, MS, FACP, SFHM
Robert Casey
Dennis Chang
Paul Grant
Tanisha Hamilton
Catriona Harrop
Nazish Ilyas
Keshav Khanijow, MD
Michael Lin
Shannon Martin
Annie Massart
Brian McGillen, MD, FHM
Nkemdilim Mgbojikwe, MD
Ethan Molitch-Hou, MD, MPH
Kirsten Nieto, MD
Charu Puri, MD
Sarah Richards, MD, FACP
Krishna Syamala
Julie Schaefer

SHM Converge 2025 - Faculty Disclosures

Faculty Disclosures
The individuals in control of content for this activity have no relevant relationships with ACCME-defined ineligible companies to disclose unless listed here. Any relevant relationships were mitigated prior to the start of this activity.

Accreditation Statement
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Credit Statement
The Society of Hospital Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Credit Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.